SummerHaven Investment Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $735K | Buy |
24,868
+514
| +2% | +$15.2K | 0.48% | 106 |
|
|
2025
Q1 | $727K | Buy |
24,354
+448
| +2% | +$13.4K | 0.51% | 95 |
|
|
2024
Q4 | $685K | Hold |
23,906
| – | – | 0.42% | 140 |
|
|
2024
Q3 | $924K | Sell |
23,906
-10,867
| -31% | -$420K | 0.56% | 43 |
|
|
2024
Q2 | $1.12M | Buy |
34,773
+452
| +1% | +$14.6K | 0.74% | 28 |
|
|
2024
Q1 | $1.33M | Buy |
34,321
+287
| +0.8% | +$11.1K | 0.83% | 6 |
|
|
2023
Q4 | $1.05M | Buy |
34,034
+368
| +1% | +$11.3K | 0.67% | 21 |
|
|
2023
Q3 | $752K | Buy |
+33,666
| New | +$752K | 0.55% | 53 |
|
|
2022
Q3 | – | Sell |
-37,193
| Closed | -$659K | – | 212 |
|
|
2022
Q2 | $659K | Hold |
37,193
| – | – | 0.44% | 123 |
|
|
2022
Q1 | $757K | Buy |
37,193
+1,699
| +5% | +$34.6K | 0.43% | 138 |
|
|
2021
Q4 | $663K | Hold |
35,494
| – | – | 0.36% | 178 |
|
|
2021
Q3 | $701K | Buy |
+35,494
| New | +$701K | 0.41% | 184 |
|